Health
UK report debunks claim that halting puberty blockers increases suicide in gender-confused youth
From LifeSiteNews
For more than a decade, the transgender movement has used a potent lie to blackmail desperate parents and feckless politicians into accepting their agenda: that if gender-confused children are not provided with sex changes – “gender-affirming care” – they will be at a high risk for suicide. Parent after parent heard the simple, deceitful question, posed to them by trans activist medical professionals: “Would you rather have a dead daughter, or a live son?”
Yet another review highlights that this claim is completely baseless. As the BBC reported on July 20: “There is no evidence of a large rise in suicides in young patients attending a gender identity clinic in London, an independent review has found.”
The report, titled “Review of suicides and gender dysphoria at the Tavistock and Portman NHS Foundation Trust: independent report,” was published by the U.K. government on July 19. Professor Louis Appleby was tasked by Health Secretary Wes Streeting to examine the evidence after LGBT activists claimed that suicide rates were spiking due to restrictions on puberty blockers, which were first implemented in 2020. The review concluded:
- The data do not support the claim that there has been a large rise in suicide in young gender dysphoria patients at the Tavistock.
- The way that this issue has been discussed on social media has been insensitive, distressing and dangerous, and goes against guidance on safe reporting of suicide.
- The claims that have been placed in the public domain do not meet basic standards for statistical evidence.
- There is a need to move away from the perception that puberty-blocking drugs are the main marker of non-judgemental acceptance in this area of health care.
- We need to ensure high quality data in which everyone has confidence, as the basis of improved safety for this at risk group of young people.
This review is devastating to virtually every single claim trans activists have been making – and Appleby even notes, in point two of his summary, that trans activists themselves are posing a real danger to gender-confused children with their irresponsible lies about suicidality. Suicide, as we have long known, is a social contagion – and trans activists are explicitly encouraging gender-confused children to claim suicidal ideation in order to acquire puberty blockers.
As the BBC reported: “The Department of Health and Social Care (DHSC) said it was vital that public discussion around the issue was handled responsibly.” It is difficult to read that statement as anything but a direct rebuke of trans activists. Appleby, a professor of psychiatry and experienced suicide researcher from the University of Manchester, warned that trans activist rhetoric could actually lead to adolescents copycatting that behavior. “One risk is that young people and their families will be terrified by predictions of suicide as inevitable without puberty blockers – some of the responses on social media show this,” he said. As the BBC noted:
In response to [trans activist] claims, the new health secretary launched an independent review led by Prof Appleby which analysed data from NHS England on suicides of patients at the Tavistock clinic, based on an audit at the trust.
Covering the period between 2018-19 and 2023-24, he found there were 12 suicides – five in the three years leading up to 2020-21 and seven in the three years afterwards.
‘This is essentially no difference,’ Prof Appleby says in his report, ‘taking account of expected fluctuations in small numbers, and would not reach statistical significance.’
He adds: ‘In the under 18s specifically, there were 3 suicides before and 3 after 2020-21.’
The Good Law Project, run by executive director Jo Maugham, is currently challenging the puberty blocker ban – and predictably, Maugham expressed his disagreement with the review, saying that he had “profound difficulties” with it. It likely will make little difference. In the U.K., the transgender narrative is in tatters – and leaders still parroting these debunked lines should take note.
DEI
TMU Medical School Sacrifices Academic Merit to Pursue Intolerance
From the Frontier Centre for Public Policy
Race- (and other-) based admissions will inevitably pave the way to race- (and other-) based medical practices, which will only further the divisions that exist in society. You can’t fight discrimination with more discrimination.
Perhaps it should be expected that a so-obviously ‘woke’ institution as the Toronto Metropolitan University (TMU) would toss aside such antiquated concepts as academic merit as it prepares to open its new medical school in the fall of 2025.
After all, until recently, TMU was more widely known as Ryerson University. But it underwent a rapid period of self-flagellation, statue-tipping and, ultimately, a name change when its namesake, Edgerton Ryerson, was linked (however indirectly) to Canada’s residential school system.
Now that it has sufficiently cleansed itself of any association with past intolerance, it is going forward with a more modern form of intolerance and institutional bias by mandating a huge 80% diversity quota for its inaugural cohort of medical students.
TMU plans to fill 75 of its 94 available seats via three pathways for “equity-deserving groups” in an effort to counter systemic bias and eliminate barriers to success for certain groups. Consequently, there are distinct admission pathways for “Indigenous, Black and Equity-Deserving” groups.
What exactly is an equity-deserving group? It’s almost any identity group you can imagine – that is, except those who identify as white, straight, cisgender, straight-A, middle- and/or upper-class males.
To further facilitate this grand plan, TMU has eliminated the need to write the traditional MCAT exam (often used to assess aptitude, but apparently TMU views it as a barrier to accessing medical education). Further, it has set the minimum grade point average at a rather average 3.3 and, “in order to attract a diverse range of applicants,” it is accepting students with a four-year undergrad degree from any field.
It’s difficult to imagine how such a heterogenous group can begin learning medicine at the same level. Someone with an advanced degree in physiology or anatomy will be light years ahead of a classmate who gained a degree by dissecting Dostoyevsky.
Finally, it should be noted that in “exceptional circumstances” any of these requirements can be reconsidered for, you guessed it, black, indigenous or other equity-deserving groups.
As for the curriculum itself, it promises to be “rooted in community-driven care and cultural respect and safety, with ECA, decolonization and reconciliation woven throughout” which will “help students become a new kind of physician.”
Whether or not this “new kind of physician” will be perceived as fully credible, however, is yet to be seen. Because of its ‘woke’ application process, all TMU medical graduates will be judged differently no matter how skilled they may be and even when physicians are in short supply. Life and death decisions are literally in their hands, and in such cases, one would think that medical expertise is far more important than sharing the same pronouns.
Frankly, if students need a falsely inclusive environment where all minds think alike to feel safe and a part of society, then maybe they aren’t cut out to become doctors who will treat all people equally. After all, race- (and other-) based admissions will inevitably pave the way to race- (and other-) based medical practices, which will only further the divisions that exist in society. You can’t fight discrimination with more discrimination.
It’s ridiculous to use medical school enrollments as a means of resolving issues of social injustice. However, from a broader perspective, this social experiment echoes what is already happening in universities across Canada. The academic merit of individuals is increasingly being pushed aside to fulfill quotas based on gender or even race.
One year ago, the University of Victoria made headlines when it posted a position for an assistant professor in the music department. The catch is that the selection process was limited to black people. Education professor Dr. Patrick Keeney points out that diversity, equity and inclusion policies are reshaping core operations at universities. Grants and prestigious research chair positions are increasingly available only to visible minorities or other identity groups.
Non-academic considerations are given priority, and funding is contingent on meeting minority quotas.
Consequently, Keeney states that the quality of education is falling and universities that were once committed to academic excellence are now perceived as institutions to pursue social justice.
Diversity is a legitimate goal, but it cannot – and should not — be achieved by subjugating academic merit to social experimentation.
Susan Martinuk is a Senior Fellow with the Frontier Centre for Public Policy and author of Patients at Risk: Exposing Canada’s Health-care Crisis.
Addictions
Ottawa “safer supply” clinic criticized by distraught mother
An Ottawa mother, who lost her daughter to addiction, is frustrated by Recovery Care’s failure to help her opioid-addicted son
Masha Krupp has already lost one child to an overdose and fears she could lose another.
In 2020, her 47-year-old daughter Larisa died from methadone toxicity just 12 days into an opioid addiction treatment program. The program is run by Recovery Care, an Ottawa-based harm reduction clinic with five locations across the city, which aims to stabilize drug users and eventually wean them off more potent drugs.
Krupp says she is skeptical about the effectiveness of the support and counseling services that Recovery Care claims to provide and believes the clinic was negligent in her daughter’s case.
On Oct. 22, the Ottawa mother testified before the House of Commons Standing Committee on Health, which is studying Canada’s opioid epidemic.
In her testimony, Krupp said her daughter was prescribed 30mg of methadone — 50 per cent more than the recommended induction dose — and was not given an opiate tolerance test before starting the program. Larisa received treatment at the Bells Corners Recovery Care location.
Krupp’s 30-year-old son, whom Canadian Affairs agreed not to name, has been a patient at Recovery Care’s ByWard Market location since 2021, where he receives a combination of methadone and hydromorphone, another prescription drug administered through the treatment program.
“Three years later, my son is still using fentanyl, crack cocaine and methadone, despite being with Dr. [Charles] Breau and with Recovery Care for over three years,” Krupp testified.
“About four weeks ago, I had to call 9-1-1 because he was overdosing,” Krupp told Canadian Affairs in an interview. “This is on the safer supply program … three years in, I should not be calling 9-1-1.”
Open diversion
Founded in 2018, Recovery Care is a partner in the Safer Supply Ottawa initiative. The initiative, which is led by Ottawa Public Health and managed by the nonprofit Pathways to Recovery, provides prescription pharmaceutical opioids to individuals who are at high risk of overdose.
Pathways to Recovery works with a network of service providers throughout the city — including Recovery Care — to administer safer supply.
Krupp says she supports the concept of safer supply, but believes it needs to be administered differently.
“You can’t give addicts 28 pills and say ‘Oh here you go,’” she said in her testimony. “They sell for three dollars a pop on the street,” she said, referring to the practice of some individuals selling their prescribed medications to fund purchases of more intense street drugs like heroin and fentanyl.
Krupp says she sees her son — and other patients of the program — openly divert their prescribed medications outside of the Recovery Care clinic in ByWard Market, where she parks to wait for him.
“[B]ecause there’s no treatment attached to [my son’s safer supply], it’s just the doctor gives him all these pills, he diverts them, gets the drugs he needs, and he’s still an addict,” Krupp said in her testimony.
Donna Sarrazin, chief executive of Recovery Care, told Canadian Affairs that Recovery Care has measures to address diversion, including security cameras and onsite security staff.
“Patients are educated at intake and ongoing that diversion is not permitted and that they could be removed from the program,” she said in an emailed statement.
“Recovery Care works to understand diversion and has continued to progress programs and actions to address the issues. Concerns expressed by the community and our teams are taken seriously,” she said.
Krupp says she has communicated her concerns about her son reselling his prescribed medications to his doctor, Dr. Charles Breau, both in-person and through faxed letters. “I never hear back from the doctor. Never,” she said.
Krupp also said in her testimony that police have spoken to her son about his diversion.
Breau did not respond to inquiries made to his clinical teams at Recovery Care or Montfort Hospital, a teaching hospital affiliated with the University of Ottawa.
Sarrazin said Breau is not able to comment on patient or family care.
In Krupp’s view, the safer supply program would be more successful if drug users were required to take prescribed medications under supervision.
“If he was receiving his hydromorphone under witnessed dosage and there was a treatment plan attached to it, I believe it would be successful,” she said.
Dr. Eileen de Villa, the City of Toronto’s medical officer of health, reinforced this point at the Oct. 22 Health Committee meeting. She said Toronto Public Health’s injectable opioid agonist therapy program — which combines observed administration with a treatment plan — has seen “incredible results.”
De Villa shared a case of a pregnant client who entered the program. “She went on to have a successful pregnancy, a healthy baby, has actually successfully completed the treatment, and is now housed and has even gained custody of her other children,” she said.
Subscribe for free to get BTN’s latest news and analysis, or donate to our journalism fund.
‘An affront to me’
Krupp also says Recovery Care fails to deliver on its promise of supporting patients’ mental health needs. Recovery Care’s website says its clinics offer “mental health programs which are essential to every treatment plan.”
Krupp and her son’s father have both requested a clear treatment plan and consistent counselling for their son. But he was started on safer supply after participating in only one virtual counselling session, she says.
She says Recovery Care has only one mental health counselor who services four of Recovery Care’s clinics. “If you’re getting $2-million-plus a year in funding, you should be able to staff each clinic with one on-site counselor five days a week,” she said.
Instead of personalized assistance, her son received “a sheaf of photocopies” offering generic services like Narcotics Anonymous and crisis helplines. “It’s almost an affront to me, as a taxpayer and a mother of an addict,” Krupp said.
Krupp says that, following her testimony to the parliamentary committee, Breau reached out to offer her son a mental health counseling session for the first time.
Sarrazin told Canadian Affairs that patients are encouraged to request counseling at any time. “Currently there is no wait list and appointments can be booked within 1 week,” she said in her emailed statement.
Class actions
Today, Krupp is considering launching a class-action lawsuit against Health Canada and the Government of Canada, challenging both the enactment of safer supply and the loosening of methadone dispensing requirements in 2017. She believes these changes contributed to her daughter’s death in 2020.
She is also considering joining an existing class-action lawsuit in B.C., which alleges Health Canada failed to monitor the distribution of drugs provided through safer supply programs.
The Pathways to Recovery initiative received $9.69-million in funding from Health Canada from July 2020 to March 2025. In June 2023, Health Canada allocated an additional $1.9 million to expand Ottawa’s safer supply program across five sites and improve access to practitioners, mental health support, housing and other services.
“I want to see that money being put to a recovery based treatment, not simply people going in and out and getting their medications and just creating this new sub-layer of addicts,” Krupp said.
This article was produced through the Breaking Needles Fellowship Program, which provided a grant to Canadian Affairs, a digital media outlet, to fund journalism exploring addiction and crime in Canada. Articles produced through the Fellowship are co-published by Break The Needle and Canadian Affairs.
Subscribe for free to get BTN’s latest news and analysis, or donate to our journalism fund.
-
National2 days ago
Liberals, NDP admit closed-door meetings took place in attempt to delay Canada’s next election
-
Digital Currency2 days ago
Conservatives urge Canadians to reject mandatory digital IDs proposed by Liberal gov’t
-
National2 days ago
Former BC Premier John Horgan passes away at 65
-
COVID-192 days ago
Blue Cross Blue Shield forced to pay $12 million to Catholic worker fired for refusing COVID shots
-
Canadian Energy Centre1 day ago
Ignoring the global picture and making Canadians poorer: Energy and economic leaders on Ottawa’s oil and gas emissions cap
-
Daily Caller1 day ago
President Of Country Hosting UN Climate Summit Defends Fossil Fuels, Slams Media And Green ‘Hypocrisy’
-
Energy1 day ago
Federal government’s ’carbon-free’ electricity target far-fetched
-
Alberta1 day ago
New red tape reporting website will help ramp up housing construction in Alberta